Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

PURPOSE: The aim of this study was to evaluate the therapeutic efficacy and safety of trastuzumab emtansine (T-DM1) for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer. METHODS: We performed a systemic review and meta-analysis of the relevant published...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bo, Ma, Qianqian, Wang, Hongqiang, Zhang, Guolei, Zhang, Huiying, Wang, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778787/
https://www.ncbi.nlm.nih.gov/pubmed/27013890
http://dx.doi.org/10.2147/OTT.S100499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778787/
https://www.ncbi.nlm.nih.gov/pubmed/27013890
http://dx.doi.org/10.2147/OTT.S100499

Ejemplares similares